Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Amerisource Health Services LLC

US Class II Ongoing · initiated 2024-11-14

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

Amerisource Health Services LLC

US Class II Ongoing · initiated 2024-11-14

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

Zydus Pharmaceuticals (USA) Inc

US Class III Ongoing · initiated 2024-11-14

Labeling: Not Elsewhere Classified - Wrong NDC number

Amerisource Health Services LLC

US Class II Ongoing · initiated 2024-11-14

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit

LNK International, Inc.

US Class II Terminated · initiated 2024-11-14

CGMP Deviations: Released product should have been rejected.

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

Keystone Industries

US Class II Terminated · initiated 2024-11-14

CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of the mixing vessel showed scratches on the sides and bottom of the…

MXBBB

US Class II Ongoing · initiated 2024-11-14

cGMP Deviations: the firm initiated a recall after notification from the distributor that product may be tainted with undeclared diclofenac and omeprazole, howe…

JAMP-FeR

Canada Type II Ongoing · initiated 2024-11-14

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

PMS-PREGABALIN

Canada Type II Ongoing · initiated 2024-11-14

Product quality - Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or …

Brands International Corporation

US Class II Ongoing · initiated 2024-11-13

CGMP Deviations: lack of adequate release testing.

Actifungi Cream

Canada Type III Ongoing · initiated 2024-11-13

Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…

Safecor Health, LLC

US Class II Ongoing · initiated 2024-11-11

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Safecor Health, LLC

US Class II Ongoing · initiated 2024-11-11

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.

Safecor Health, LLC

US Class II Ongoing · initiated 2024-11-11

cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.